Rodano, Italy

Antonella Malcangi

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Antonella Malcangi: Innovator in Pharmaceutical Production

Introduction

Antonella Malcangi is a prominent inventor based in Rodano, Italy. She has made significant contributions to the field of pharmaceutical production, particularly through her innovative processes. With a total of 2 patents, her work focuses on improving the efficiency and safety of antibiotic production.

Latest Patents

Malcangi's latest patents include a procedure for the production of tiacumicin B. This invention involves the fermentation of a microorganism capable of producing tiacumicin B, specifically utilizing a culture broth that contains emulsifiers like ethoxylated castor oil, along with antifoaming products and vegetable oils. Another notable patent is for an improved process for the production of daptomycin. This process employs fermentation in the presence of n-decanal or oil as sources of the n-decanoyl side chain, which helps to reduce toxicity effects on bacteria and eliminates the need for solvents in the feeding solution.

Career Highlights

Throughout her career, Antonella Malcangi has worked with notable companies such as Antibioticos S.p.A. and Olon S.p.A. Her expertise in pharmaceutical processes has made her a valuable asset in these organizations, contributing to advancements in antibiotic production.

Collaborations

Malcangi has collaborated with esteemed colleagues, including Guido Trione and Gianluca Bertetti. These partnerships have fostered innovation and have been instrumental in her research and development efforts.

Conclusion

Antonella Malcangi's contributions to pharmaceutical production through her innovative patents highlight her role as a leading inventor in the industry. Her work continues to influence the field and improve antibiotic production processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…